Diclazuril-13C3,15N2

Diclazuril-13C3,15N2

• UNSPSC Description: Diclazuril-13C3,15N2 is 13C and 15N labeled Diclazuril. Diclazuril (R-64433), a benzeneacetonitrile derivative, is a potent and orally active anticoccidial agent. Diclazuril can be used for the research of certain infectious and parasitic diseases, including coccidiosis, acute toxoplasmosis, equine protozoal pyoencephalitis (EPM) et.al[1][2][3].
• Target Antigen: Antibiotic; Isotope-Labeled Compounds; Parasite
• Type: Reference compound
• Related Pathways: Anti-infection;Others
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/diclazuril-13c3-15n2.html
• Smiles: ClC1=CC=C(C(C(C(Cl)=CC(N2[15N]=[13CH][13C]([15NH][13C]2=O)=O)=C3)=C3Cl)C#N)C=C1
• Molecular Weight: 412.60
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Diaferia, M., et al., Efficacy of toltrazuril 5 % suspension (Baycox(R), Bayer) and diclazuril (Vecoxan(R), Janssen-Cilag) in the control of Eimeria spp. in lambs. Parasitol Res, 2013. 112 Suppl 1: p. 163-8.|[3]http://www.huvepharma.com/products/view/190
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported